Top 50 Biotech Startup Investors in Denmark in July 2025
A list of 50 angel investors and VC (Venture Capital) funds that invest in Biotech startups based in Denmark. We rank investors based on the number of investments they made in Biotech companies from Denmark. We update this investor list every month.Top 50 Biotech Startup Investors in Denmark in July 2025
Investor | Biotech Denmark investments |
---|---|
Novo Holdings | 28 |
BioInnovation Institute | 19 |
Vaekstfonden | 16 |
Export and Investment Fund | 13 |
Vaekstfonden | 12 |
Seed Capital | 9 |
PSV | 8 |
Sunstone Life Science Ventures | 7 |
Nordic Foodtech VC | 6 |
Gilde Healthcare | 5 |
RA Capital Management | 4 |
West Hill Capital | 4 |
VF Venture | 4 |
Ysios Capital | 4 |
Oskare Capital | 4 |
HealthCap | 4 |
EIR Ventures | 3 |
DSM Venturing | 3 |
Per Falholt | 3 |
The Footprint Firm | 3 |
PINC | 3 |
Thia Ventures | 3 |
Nicholas Francis | 3 |
NOON Ventures | 3 |
ACME Capital | 3 |
Sofinnova Partners | 3 |
Blue Horizon Corporation | 3 |
Ugly Duckling Ventures | 3 |
Atlantic Labs | 3 |
CAPNOVA | 2 |
Symrise | 2 |
Lundbeckfonden Ventures | 2 |
SOSV | 2 |
Wellcome Trust | 2 |
Wellington Partners | 2 |
Novo Nordisk | 2 |
Innovations Kapital | 2 |
Inkef | 2 |
Giampaolo Cagnin | 2 |
Aescap Venture | 2 |
Industrifonden | 2 |
FundersClub | 2 |
Innovation Fund Denmark | 2 |
The Yield Lab Europe | 2 |
Dawn Biopharma | 2 |
+ND Capital | 2 |
Northzone | 2 |
Johnson & Johnson Development Corporation | 2 |
Novo Ventures | 2 |
M Ventures | 2 |
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- United States, Denmark, United Kingdom
Portfolio highlights
- Supira Medical — Next Generation Solution for Temporary Mechanical Circulatory Support Developing a low-profile, high-flow percutaneous ventricular assist device (pVAD) for high risk coronary intervention and cardiogenic shock. Clinical Need Percutaneous ventricular assist devices (pVADs) are placed to provide temporary mechanical support, assisting the native pumping action of
- Sparrow Quantum — Sparrow Quantum, a global leader in quantum photonic chip technology. Explore innovative solutions driving advancements in quantum computing, communication, and beyond. Stay ahead with cutting-edge technologies shaping the future.
- Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
BioInnovation Institute is a biotechnology startup that offers entrepreneurs and researchers in life science. Early-stage life science start-ups are supported with up to 10 million DKK in funding, business acceleration, network, labs, and office space. It helps to early-stage start-ups within human health and planetary health. The startup'smission is to use its knowledge, network, funding, and infrastructure to incubate world-class life science and catalyze the commercialization of new solutions through start-ups.BioInnovation Institute was founded in 2018 and is based in Denmark.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Convertible Note, Pre-Seed, Debt Financing
- Denmark, Germany, Switzerland
Portfolio highlights
- NorFalk — Explore NorFalk and its new generation surfactants. Discover our specializations and subscribe to our newsletter today.
- ArcanaBio — ArcanaBio is developing realtime biosurveillance solutions that minimize workplace disruptions and support health & wellness
- Fuse Vectors — Fuse Vectors is disrupting the manufacturing process in order to provide universal access to gene therapy.
Vaekstfonden – The Danish Growth Fund – is the Danish state's investment fund. We strive to improve access to risk capital to enable Danish businesses to innovate, and to generate growth and new jobs. In close collaboration with banks and domestic and international private investors, we finance companies from all sectors nation-wide. We canaccompany you for the entire journey – from your company’s infancy through growth phases to expansion abroad and even to an initial public offering.
Show more
Investment focus
- Software, Information Technology, SaaS
- Seed, Funding Round, Pre-Seed
- Denmark, United States, United Kingdom
Portfolio highlights
- Wedio — Buy & Rent professional film equipment from trusted creators near you. Buy & rent cameras, lenses, drones with Global Coverage. Explore
- Keepit — The Keepit Cloud is the most cost-effective solution on the market with 20+ years of experience. Learn more about our next-level data protection services
- kleen hub — Kleen hub is Denmark's first digital return system for reusable coffee cups and food packaging.
Denmark's Export and Investment Fund (EIFO) serves as a single point of contact for Danish firms seeking risk-tolerant government finance. We aspire to help successful enterprises that can expand the Danish economy and green the world on a daily basis, guided by professionalism and an international perspective.
Show more
Investment focus
- Software, Biotechnology, Information Technology
- Seed, Series A, Funding Round
- Denmark, United States, United Kingdom
Portfolio highlights
- Saildrone — Saildrone is the world leader in oceangoing autonomous surface vehicles, providing unrivaled payload, range, and reliability from an uncrewed system.
- Fuse Vectors — Fuse Vectors is disrupting the manufacturing process in order to provide universal access to gene therapy.
- Sparrow Quantum — Sparrow Quantum, a global leader in quantum photonic chip technology. Explore innovative solutions driving advancements in quantum computing, communication, and beyond. Stay ahead with cutting-edge technologies shaping the future.
Vaekstfonden – The Danish Growth Fund – is the Danish state's investment fund. We strive to improve access to risk capital to enable Danish businesses to innovate, and to generate growth and new jobs. In close collaboration with banks and domestic and international private investors, we finance companies from all sectors nation-wide. We canaccompany you for the entire journey – from your company’s infancy through growth phases to expansion abroad and even to an initial public offering.
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Funding Round, Pre-Seed
- Denmark, United States, Norway
Portfolio highlights
- Wedio — Buy & Rent professional film equipment from trusted creators near you. Buy & rent cameras, lenses, drones with Global Coverage. Explore
- Keepit — The Keepit Cloud is the most cost-effective solution on the market with 20+ years of experience. Learn more about our next-level data protection services
- kleen hub — Kleen hub is Denmark's first digital return system for reusable coffee cups and food packaging.
Seed Capital invests in Danish tech businesses with global ambitions. We are focused on "late seed"-stage companies, typically investing 1-3 MEUR in rounds of 1-6 MEUR. Proud backers of Trustpilot, Vivino, Lunar, Templafy, Dixa, Forecast, and many other great companies.
Show more
Investment focus
- Software, Health Care, SaaS
- Seed, Funding Round, Series A
- Denmark, United States, United Kingdom
Portfolio highlights
- Tembi — Market Intelligence platform with deep market data, insights and predictions for B2B companies that look for a competitive edge.
- Fortiv — We help enterprise Resilience teams implement a Business Continuity Management System
- Embankment Group — Specializing in environmental recruitment, we connect top talent with leading projects. Contact us for tailored job searches today!
PreSeed Ventures are the preferred travel companion for trailblazing founders when they set out on the journey of transforming startup dreams to successful businesses. Founded in 2000 they have an exceptional track record of spotting, fostering and financing tomorrow’s winners in syndication with top-tier investors locally and globally. As the namesuggests, PreSeed Ventures operates at the earliest stages, where founders need the professional, operational & systematic support of a VC, but the risks are still too high for most VCs in seed stages. Yet to the powerhouse of experts behind PreSeed Ventures, who have experience from hundreds of startup journey in the pre-seed stage, it is an opportunity to support and nurture the growth of promising startups on the rise, minimizing the time and risk to the next investment round.PreSeed Ventures has grown out of the technological research environment at Denmark’s Technical University, DTU. In 2020 they launch their first full blown commercial venture fund, yet continuing to be a subsidiary company to the university.
Show more
Investment focus
- Software, Information Technology, SaaS
- Seed, Pre-Seed, Funding Round
- Denmark, United States, United Kingdom
Portfolio highlights
- Cellugy — Biomaterial to Replace Plastic
- ZTLment — We empower online platforms and marketplaces to seamlessly hold, manage, and distribute funds in real-time, with full automation and compliance.
- Dynelectro — Dynelectro is a Danish solid oxide electrolyser equipment manufacturer with proprietary innovation to lower the total cost of hydrogen. Dynamic operation enables load-follow of fluctuating renewable energy, delivering over 85% electrical efficiency prior to integrating with industrial heat sources. With fully reversable operation, electricity generation adds substantial value and flexibility with grid ancillary services. Small-scale units begin at 40 kW with 12-month lead time. Large-scale systems start at 1 MW with project-based lead time.
Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Funding Round, Series B, Series A
- Denmark, Sweden, Switzerland
Portfolio highlights
- Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
- Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
- Rewind Therapeutics — Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medicalpractitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.
We are investing in #FutureFood. Nordic FoodTech VC is the first fund in the Nordics investing explicitly in the future of food
Show more
Investment focus
- Biotechnology, Life Science, Water
- Seed, Series A, Funding Round
- Finland, Sweden, Denmark
Portfolio highlights
- EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
- Endless Food — Endless Food Co is a food innovation firm focusing on the junction of pleasure and sustainability. Endless Food Co was pulled together by a common idea that the transition to a greener and more egalitarian future food system will be driven by flavor, and having spent the last decade pioneering sustainable gastronomy
- Happy Plant Protein — Changing the way plant proteins are made
Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. It has over €800 million ($900 million) under management and is actively looking to lead new investments in digital health, diagnostics, medical devices, therapeutics and healthcareservices. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series C, Series A
- United States, The Netherlands, Germany
Portfolio highlights
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
- Spyglass Pharma — Spyglass Pharma focuses on the development of novel treatments for chronic ophthalmic diseases based on technology. The company designs to deliver multiple drugs to address additional ophthalmic indications.
- MicroTransponder — MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases. Its therapies include paired vagus nerve stimulation system (Paired VNS System) and wireless neurostimulation system for the treatment of chronic pain, post-stroke upper limb mobility issues, and variousneurological indications that enable healthcare practitioners to treat post-stroke upper limb mobility issues.Founded in 2007, MicroTransponder is headquartered in Dallas, Texas.
RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. The company's team has been investing since 2002 and is comprised of professionals with training in biology, chemistry, and medicine and also has industry and business development experience at the executive and boardlevels. The company invests in companies with promising technologies and products.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series B, Series C, Post-IPO Equity
- United States, United Kingdom, Canada
Portfolio highlights
- Vor Biopharma — Shield the healthy cells, expose the cancer - Vor Bio (also known as Vor Biopharma) aims to cure blood cancers through cell and genome engineering.
- Commons Clinic — Commons Clinic is a group of world class orthopedic surgeons in Los Angeles, CA. Our orthopedic specialists provide expert care from start to finish.
- Spyglass Pharma — Spyglass Pharma focuses on the development of novel treatments for chronic ophthalmic diseases based on technology. The company designs to deliver multiple drugs to address additional ophthalmic indications.
West Hill Corporate Finance is a leading private equity venture capital firm providing EIS qualifying high-growth investments to private individuals.
Show more
Investment focus
- Software, Health Care, Financial Services
- Funding Round, Series A, Seed
- United Kingdom, Denmark, Germany
Portfolio highlights
- Algiecel — ALGIECEL - Securing CO2 neutrality with carbon capture as a service Microalgae Cultivation – Easily scalable with modular photobioreactorsALGIECEL is transforming CO2 emissions and LED light into microalgae biomass and Oxygen. The company has developed a plug & play photobioreactor that can be stacked and packed as it is fitting intostandard shipping containers. The reactor is easily installable and requires little technical know-how from small and mid-size industrial clients.ALGIECEL has designed a novel business model that transforms the cost challenge of CO2 removal into a profitable business opportunity across the entire value chain through revenue sharing from the microalgae biomass and carbon credit sales.ALGIECEL´s primary target markets for the application of the photobioreactor will be the biogas and fermentation sectors. In these fast-growing industries many sites are too small for large power-to-x projects to reduce CO2 emissions. Here, ALGIECEL aspires to help in solving the CO2 challenge with our modular carbon capture technology and revenue sharing business model.
- Cercare Medical — Cercare Medical designs and develops a software tool for supporting acute stroke management, helping clinicians to evaluate the effect of a stroke. The software draws up the infarct-area within 30 seconds, locate perfusion area from images within 30 seconds and evaluate mismatch and generate a volume number of salvageable tissue. Cercare Medicalwas incorporated in 2013 under the name Combat Stroke and is based in Denmark.
- ATLANT 3D — Micro and nanodevices are built and tested within days instead of months or years.
Vaekstfonden makes equity investments in Danish companies with a track record as well as in young entrepreneurial, innovative enterprises with an ambition for global growth.
Show more
Investment focus
- Software, Biotechnology, SaaS
- Seed, Funding Round, Series A
- Denmark, United Kingdom, Iceland
Portfolio highlights
- Kollektiv — Unleash your best self with tailored training plans, learning and support for running, swimming and cycling - from world-class-coaches and ex-athletes.
- Performativ — Performativ develops modern solutions for the asset and wealth management industry. Our clients span from small investment advisors to enterprise banks.
- Onomondo — Onomondo is a global IoT network. Our IoT SIM and cloud platform future proof your devices with full data transparency, freedom to leave, and no third parties.
Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- Spain, United States, Switzerland
Portfolio highlights
- ReproNovo — New Scientific Approaches in Reproductive Medicine. At ReproNovo, we are passionate about bringing the dream of parenthood to life.
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
- Neurona Therapeutics — Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four neuroscientists and stem cell pioneers at The University of California, San Francisco. They are focused on the discovery and development of cell-based therapies to treat intractable neurological disease. Its initial aim is to generate therapeuticcompositions of a specific type of nerve cell (or neuron) for targeted delivery into the injured nervous system. Based on nearly two decades of research, they believe that particular subpopulations of neurons have the unique ability to integrate and repair dysregulated neural circuits. Its talented team of scientists, scientific advisors, and board directors is working to accelerate breakthrough treatments for patients with significant unmet medical needs.
Oskare Capital is a venture capital firm.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Seed, Pre-Seed, Series A
- Italy, Denmark, United Kingdom
Portfolio highlights
- Leva Clinic — Leva Clinic offers health care services for people with chronic pain. Their medical services include back pain, cancer pain, endometriosis, facial pain, fibromyalgia, joint pain, knee pain, multiple sclerosis, sciatica, and so on.
- Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
- Herbolea Biotech — Unique bio-processing technologies NATURAL, SOLVENT-LESS Botanical extraction Learn more
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Funding Round
- United States, Sweden, France
Portfolio highlights
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- HelloBetter — HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services.
- Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
EIR Ventures is a new Life Science Venture Group in the Nordics.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Seed, Funding Round
- Denmark, Sweden, United States
Portfolio highlights
- Henlez — Henlez is a Danish startup company.
- ArgusEye — ArgusEye - Innovative Sensor Solutions - Real-time monitoring and control of biological systems and processes - Patented sensor technology
- Moleculent — Moleculent is adding a functional layer of biology to pave the way for unparalleled advancements in biological research.
Innovators in nutrition, health, and beauty. Together, we bring progress to life by combining the essential, the desirable, and the sustainable.
Show more
Investment focus
- Biotechnology, Health Care, Manufacturing
- Series A, Funding Round, Series B
- United States, Canada, Israel
Portfolio highlights
- Vivici — Our mission is to meet the world's growing need for sustainable, nutritious and great tasting animal-free proteins.
- NutriLeads — NutriLeads is an innovative startup that develops nutritional ingredients with demonstrated health effects. NutriLeads aims to catalyze nutritional health innovation in the food industry by partnering with relevant companies to identify promising lead ingredients, develop sustainable and commercially viable production processes, and initiatescientific & clinical programs to substantiate the health effects of these ingredients. Together we will bring the benefits of the proprietary ingredients to patients and consumers.
- Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
A passion and vision for chemistry and biotechnology led Per (born 1958) to Novo A/S, where he started his career as a research chemist. He subsequently held several managerial positions developing products for the detergent industry and rose to Director for Application Technology in the company’s new enzyme development division in 1995.Hemoved to Raleigh, N.C., to head the company’s U.S. application technology unit in 1997, returning to Denmark three years later as Corporate Vice President of the Enzyme Development and Application division. In April 2000, Per merged the Research and Development division into the newly formed Enzyme Business R&D.Per assumed his current position following Novozymes’ demerger from Novo Nordisk in 2000. As chief science officer, he has helped Novozymes develop a unique industrial biotechnology platform which delivers solutions to meet customer needs and support growth.Per holds a M.Sc. in Chemical Engineering from Technical University of Denmark (DTU). Committed to promoting education and research within the sciences, he was appointed Honorary Professor at DTU’s Institute for Systems Biology in 2010 and became Chairman of the Board in 2013. He is also Chairman of the Young Scientists association in Denmark.Per’s current external positions also include Chairman, DTU, board member of DHI Group, board member of ARTs Biologics A/S, and member of the Danish Council for Research Policy.
Show more
Investment focus
- Biotechnology, Robotics, Life Science
- Seed, Pre-Seed, Series A
- Denmark
Portfolio highlights
- Reshape Biotech — Fully digital microbiology developed by Reshape Biotech
- Synamics Therapeutics — Synamics Therapeutics uses AI and predictive modeling for precision oncology and improved drug discovery. Our adaptive medicine approach helps prolong drug effectiveness and improves outcomes for patients with intractable cancers. Learn more about Synamics Therapeutics and how we leverage AI for personalized, adaptive cancer therapies.
The Footprint Firm is an advisory and investment company with a sole focus on sustainability.
Show more
Investment focus
- Software, Finance, Renewable Energy
- Seed, Pre-Seed
- Denmark
Portfolio highlights
- Cellugy — Biomaterial to Replace Plastic
- Dynelectro — Dynelectro is a Danish solid oxide electrolyser equipment manufacturer with proprietary innovation to lower the total cost of hydrogen. Dynamic operation enables load-follow of fluctuating renewable energy, delivering over 85% electrical efficiency prior to integrating with industrial heat sources. With fully reversable operation, electricity generation adds substantial value and flexibility with grid ancillary services. Small-scale units begin at 40 kW with 12-month lead time. Large-scale systems start at 1 MW with project-based lead time.
- Kvasir Technologies — Imagine a world without fossil fuelsThis is where we come in! We have invented a solution that makes this possible already in 2050.
PINC was launched as Paulig Incubator in 2018 to help Paulig stay in the forefront of relevant innovations, as well as to contribute to a tastier, healthier and more sustainable planet. Today, our ambition is the same, but we have developed into a corporate venture arm. We aim for strategic, financial, and societal impact in our investments,fostering a sustainable food system for tomorrow. We are investing across the agrifood value chain in three primary impact themes: Improve planetary health and diet within the current food system: This includes innovations in agriculture and food security, such as advanced crop breeding or green fertilizers, innovative ingredients and next generation healthy foods, as well as solutions for tracking and improving climate and nature. Novel technologies to feed 10 BN people by 2050: Technologies needed to sustainably produce enough food for our growing population. This includes food production without land use change, such as precision fermentation and cell-culture. A circular system for food & materials: Regardless of whether we grow our food in soil or in bioreactors, the system needs to be circular. Some examples are upcycled ingredients, food from unused sources, new coating and packaging solutions, as well as technologies to prevent or make better use of side streams. We are looking for entrepreneurs in an attractive market space with an intrinsic drive to find a solution to the problem they are addressing, a clear and scalable plan for success, a reliable team and partners whom we can trust and work closely with.
Show more
Investment focus
- Biotechnology, Food and Beverage, Food Processing
- Seed, Pre-Seed, Series A
- Sweden, Denmark, United Kingdom
Portfolio highlights
- Elaniti — Elaniti uses recent advances in machine learning and DNA sequencing to make insights on soil biology accessible to farmers and agronomists, empowering precise decision making. Our proprietary outcome-based predictive analytics service, correlates soil biology with vital crop health outcomes like yield, disease prevalence and nutrient content. Thisenables growers to save time and money, for instance by improving the efficiency with which inputs are used, whilst also supporting environmental and sustainability objectives.Through our unique crop prediction insights, our goal is to demonstrate the value of soil’s complex biological makeup, enabling a viable, de-risked, and data-driven transition to Net-Zero agriculture.
- EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
- BlueRedGold — Discover BlueRedGold - the home of exquisite Swedish Saffron, ethically grown and harvested with precision in Sweden. Experience the unparalleled quality of our saffron, perfect for culinary enthusiasts and chefs alike. Join us in embracing sustainable luxury.
WE ARE AN EARLY-STAGE INVESTOR IN ONE OF THE MOST DYNAMIC AND ESSENTIAL FIELDS OF CURRENT HUMAN ENDEAVOR WE BRING ROBUST INVESTOR MUSCLE TO EARLY-STAGE VENTURES INVESTOR A specialized and focused investor Resources Powerful industry, substance and business resources Experience Wide networks and longstanding experience Team Yet, adaptability and speed of a lean, self-financed team
Show more
Investment focus
- Biotechnology, Food and Beverage, Health Care
- Series A, Seed, Series B
- United States, France, Denmark
Portfolio highlights
- EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
- Protealis — Sustainable plant proteins for Europe
- Switch Bioworks — Switch Bioworks engineers symbiotic microbes to produce sustainable nitrogen fertilizer under the control of precise genetic circuits.
Nicholas Francis is Co-founder at framebunker
Show more
Investment focus
- SaaS, Robotics, Software
- Seed, Series A
- Denmark, United States
Portfolio highlights
- Waterplan — Waterplan is a SaaS platform for companies to manage water availability in their facilities.
- Reshape Biotech — Fully digital microbiology developed by Reshape Biotech
Noon Ventures is a Copenhagen-based, early-stage venture investor established in 2020. We invest in proven transformative technologies with the potential to impact environmental or climate challenges.
Show more
Investment focus
- Biotechnology, AgTech, Farming
- Seed, Series A
- Denmark
Portfolio highlights
- Agrobiomics — Agrobiomics is a danish Agritech start-up, harnessing the power of soil bacteria and their metabolites as new biostimulants to help crops cope with abiotic stress such as drought.
- Enduro Genetics — Bioproduction can be difficult to scale to large cultivation volumes while keeping titers high. By applying game-changing synthetic biology technology, Enduro Genetics empowers our partner companies to maximize performance of all cells cultivated from their production strains.
- Lotus Microsystems — Lotus Microsystems offers miniaturized highly integrated point of load power converters. The devices are engineered for portable electronics manufacturers ready for usage whenever tiny power supply units are needed. Our devices offer up to 72% reduction in footprint compared to existing solutions with higher efficiency and reliability. Our plug andplay solutions enable our customers to innovate their electronics without worrying about power supply units.
ACME is a venture capital firm investing in iconic founders disrupting massive markets.
Show more
Investment focus
- Software, Health Care, Internet
- Seed, Series A, Series B
- United States, Denmark, Canada
Portfolio highlights
- Laurel — Time by Ping frees lawyers from timekeeping so they can focus on their work, and firms can understand where time is being spent.
- Muon Space — Earth intelligence for a Safe and Resilient World.
- True Anomaly — True Anomaly Space
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- France, United States, United Kingdom
Portfolio highlights
- SafeHeal — SafeHeal is a clinical stage medical device manufacturer focusing on the development of anastomosis protection devices, including Colovac, for colorectal surgery.
- Actithera — Actithera is a molecular radiotherapeutic company that develops radioligand therapies. It translates medicinal chemistry insights into new radioligand therapies (RLTs) and applies various molecular design strategies, including covalent targeting and an isotope-agnostic philosophy, to invent RLTs with significant differentiation and largertherapeutic windows.
- One Biosciences — One Biosciences unlocks routine analysis of tumor heterogeneity through AI-powered single-cell technologies, transforming precision medicine.
Blue Horizon is accelerating the transition to a sustainable food system that delivers outstanding returns for the planet and people.
Show more
Investment focus
- Food and Beverage, Food Processing, Biotechnology
- Seed, Series A, Pre-Seed
- United States, United Kingdom, Germany
Portfolio highlights
- WOW EARN — WOW EARN connects users to the blockchain, enabling them to mine, earn, and trade via decentralised mining, earning, and trading systems.
- EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.
- foodforecast — AI supported solution to reduce food waste.
At Ugly Duckling Ventures, we make capital, know-how, and real-world application available to Nordic ventures at the seed & pre-seed stage. We are operational by nature and want to get in the grind as we excel at getting early-stage ventures ready for scale.
Show more
Investment focus
- Information Technology, Software, Cyber Security
- Seed, Pre-Seed, Funding Round
- Denmark
Portfolio highlights
- Eupry — Be in full control of your temperature compliance at all times. Collect temperature monitoring, mapping, and calibration in one GxP-compliant solution.
- Skyfora — Skyfora combines scientific understanding of tropical storms with computer vision, machine learning and IoT technologies.
- Clock & Cloud — AI-driven platform delivering actionable geopolitical intelligence for proactive decision-making and enhanced business security
Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures. <br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.
Show more
Investment focus
- Software, Health Care, Financial Services
- Seed, Pre-Seed, Series A
- Germany, Switzerland, United States
Portfolio highlights
- Pletor — The platform where marketers and creatives explore and build custom design agents to achieve 100x more. Like Zapier for visual marketing.
- Omnisent — Omnisent is a technology company focused on transforming the way we understand and interact with the physical world by extracting intelligence from sound. Their core innovation lies in pairing ultra-low power sonic devices with a Large Acoustic Model (LAM) specifically trained on non-speech audio, enabling the conversion of ambient sounds intoreal-time, actionable intelligence
- Grouphug — Grouphug turns noisy WhatsApp groups into organized, intelligent pages.
They are an investment and development company providing capital, solid business experience and a strong network in order to turn innovative ideas into successful businesses. They cover all of Denmark from their offices in Aarhus, Roskilde, Copenhagen, Viborg and Kalundborg.
Show more
Investment focus
- Software, Information Technology, Internet
- Funding Round, Seed, Pre-Seed
- Denmark, United States, India
Portfolio highlights
- Ulobby — Ulobby is an automated tool for stakeholder management and political monitoring
- Mechanic Miner — Mechanic Miner is a 2D construction/survival game with mechanical steam-powered machines. You are stranded on a strange and forbidding planet, where survival is made difficult by hostile animals and plant life. From your home world you did bring a multitool, which is able to craft any kind of machine part - provided the requisite rawmaterials can be found. Relying solely on the technology you brought, you set out to explore a whole world. You can progress through the game by acquiring new types of steam-powered technology elements, that are necessary to delve deeper into the diverse biomes of the planet, and perhaps, ultimately, discover the means to escape. You can construct any kind of machine of your own design - and any kind of machine can be simulated by the game's physics engine - and of course, designs can be shared with your friends.
- ResoTher Pharma — ResoTher Pharma is a privately held biotechnology company located in Copenhagen, Denmark. The company is focused on developing peptide-based drugs derived from the endogenous immunomodulator Annexin 1A as resolution therapy for diseases where neutrophil-driven inflammation plays a key pathological role.
About 30,000 products - 6,000 customers in roughly 160 countries. First synthesis of vanillin in 1874.
Show more
Investment focus
- Beauty, Internet, Cosmetics
- Series A, Seed
- United States, Denmark
Portfolio highlights
- Phlur — Phlur brings you fine fragrances created by world-class perfumers, our fragrances are meticulously crafted with modern sensibility and radical transparency.
- EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
- Sunday2Sunday — A haircare brand created for active women that provides quality products to cleanse and refresh textured hair pre- and post-workout.
Lundbeckfond Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by the Lundbeck Foundation. The structure as an evergreen fund allows flexibility in the investment approach and the possibility, when appropriate, to take a long-term perspective in the investments. On an annual basis, LundbeckfondVentures invests up to € 50 million.Lundbeckfond Ventures is a financially driven venture fund generating returns to support the group's activities and operating independently from the Lundbeck Foundation’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series B, Series A, Series C
- United States, Denmark, United Kingdom
Portfolio highlights
- ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
- Kvantify — Quantum computing will revolutionize many aspects of computing. We can help your business harness the full potential of Quantum Computing and High-Performance Computing today.
- Notify Therapeutics — Notify Therapeutics develops therapies for the treatment of infertility. By targeting the early and hormone-independent phase of egg maturation, the company aims at developing a first-in-class treatment for infertile women, who do not benefit from standard hormone therapy. It utilizes drug-inducing factors that regulate the intracellular AKTpathway and target the early and hormone-independent phase of egg maturation for the treatment.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates.
HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Seed, Convertible Note, Pre-Seed
- United States, India, United Kingdom
Portfolio highlights
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- NovoNutrients — NovoNutrients is working to turn waste CO2 into high-value, low-cost proteins and additives for food and feed by developing proprietary microbes and advanced gas fermentation systems.
- Sodex Innovations — Sodex Innovations is a company which is specialized in developing assistance-systems and automating-kits for excavators
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science.
It was founded in 1936 and headquartered in London, England.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Grant, Series C, Funding Round
- United States, United Kingdom, Germany
Portfolio highlights
- RenBio — RenBio develops antibody-based therapeutic solutions for the treatment of cancer and inflammatory diseases. RenBio's proprietary MYO technology involves in the development of antibody therapeutic that helps in treating rare diseases, viral infections, autoimmune diseases, and more by using DNA blueprint and antibody factory.
- Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
- Cultivarium — We develop molecular, hardware and software tools to accelerate the adoption of microbes for beneficial biotechnologies.
Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Funding Round
- Germany, United States, United Kingdom
Portfolio highlights
- Hilo — Get stress-free readings round the clock with Hilo's clinically validated blood pressure monitor. Learn more
- HepaRegeniX — HepaRegeniX is developing drugs for treating acute and chronic liver diseases that effectively restore the regenerative capacity of hepatocytes. The therapeutic concept is founded on research by Professor Lars Zender’s group at the University Hospital Tübingen, which identified mitogen-activated protein (MAP) kinase kinase 4 (MKK4) as a keyregulator of liver regeneration. Work by Professor Zender’s team showed that using small RNA molecules to suppress MKK4 gene expression restored the regenerative capacity of hepatocytes, even in severely diseased livers. Founded in 2015, HepaRegeniX is developing small-molecule MKK4 inhibitors to treat liver disorders, potentially including nonalcoholic steatohepatitis.
- Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
Show more
Investment focus
- Biotechnology, Therapeutics, Health Care
- Series A, Series C, Seed
- United States, Denmark, France
Portfolio highlights
- ElevateBio — We provide the tools, time, and environment to innovate and accelerate development of life-saving Cell and gene therapies.
- Tanai Therapeutics — Tanai Therapeutics develops novel therapeutics for people living with obesity and obesity-related complications.
- Eikonizo Therapeutics — Eikonizo is developing life-changing treatments by producing brain-penetrant small compounds and utilizing in vivo target engagement approaches to speed therapeutic discovery.
InnovationsKapital was founded in 1994 and is a leading independent venture capital firm for innovative growth companies in the Nordic region. The business, carried out from offices in and Stockholm, Gothenburg and New York, is focused on investments within ICT and Healthcare & Life Sciences, dynamic sectors that are rapidly expanding and whereNordic research plays an important role. The capital is provided by highly reputable Swedish and international institutional investors.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Funding Round, Series B, Series C
- Sweden, Denmark, United States
Portfolio highlights
- Silecs — PiBond manufactures materials used in electronic devices, including patterning materials for semiconductors and optical materials. We also develop complete solutions that allow our clients to focus on creating innovative products.
- SantoSolve — SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. Nosignificant adverse effects associated with the treatment was reported.The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
- Action Pharma — Action Pharma A/S operates as a research and development focused biotechnology company. It discovers and develops new drugs and treatment concepts to treat cardiovascular disease and inflammatory diseases, as well as metabolic diseases, such as type-II diabetes and obesity. The company's product pipeline includes AP214, a modifiedÃMSH-peptide analogue for the treatment of post-surgical kidney injury associated with cardiac surgery; and AP1030 and AP11 series, oral anti-diabetic (OAD) for the treatment of type-II diabetes associated with overweight/obesity. Its product pipeline also comprise AP1189, an oral anti-inflammatory compound for the treatment of inflammatory diseases, such as inflammatory bowel disease and rheumatoid arthritis; and AP405, a modified MSH peptide analogue for the treatment of inflammatory skin diseases, such as atopic dermatitis. The company was founded in 2000 and is based in Holte, Denmark.
SVB - Europe's biggest online shop for boating equipment and accessories! Worldwide delivery, even directly on-board!
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- The Netherlands, United States, Germany
Portfolio highlights
- Onward — Working to restore movement, independence, and health in people with spinal cord injury.
- Draupnir Bio — Draupnir Bio is developing new innovative therapies for patients.
- Provable Markets — A comprehensive suite of trading & trade management solutions for the front, middle, and back office
Giampaolo’s aim has always been to apply a disruptive approach to functional food ingredients and that’s how he founded Italiana Ingredienti in ’89 and Campus in ’05. Both companies have been acquired, Italiana Ingredienti by Chr. Hansen in ‘99 and Campus by Firmenich in ’18. Today he serves as Founder and Chairman at Hi-Food, an Italian companyproviding key functional ingredients to food companies, and as a business Angel Investor in several startups.
Show more
Investment focus
- Biotechnology, Food and Beverage, Plant-Based Foods
- Seed, Pre-Seed
- Italy, Denmark
Portfolio highlights
- Chromologics — Chromologics produce natural sustainable colors. Our flagship product is ChromoRed which performs better than existing natural, red colorants. ChromoRed is also applicable with vegan, kosher and halal diets.
- Dreamfarm — We are a team of food-lovers 100% made in Italy! We dreamt of a better, tastier, more sustainable future and decided to join forces to create something special.
The Aescap funds invest in highly innovative publicly traded biotech/life sciences companies. We're able to select the promising companies
Show more
Investment focus
- Biotechnology, Pharmaceutical, Chemical
- Series A, Series B, Funding Round
- United Kingdom, Austria, Belgium
Portfolio highlights
- Orphazyme — Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, and is based on discoveries emerging from the academic laboratory of its scientific founders: Professor Marja Jäättela and Thomas Kirkegaard Jensen from the Danish Cancer Society (Kræftens Bekæmpelse).Orphazyme is based in Copenhagen and has established collaborations with top-tier academic institutions in Europe and USA.
- Avantium — Build a sustainable future with Avantium. Leading the change in green chemistry and innovative solutions.
- F-Star Therapeutics — F-star is a clinical stage biotech developing next generation immunotherapies to transform the lives of patients with cancer. We are developing transformational cancer immunotherapies for patients who have few remaining options.
Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.
Show more
Investment focus
- Software, Biotechnology, Information Technology
- Funding Round, Series A, Seed
- Sweden, United States, Denmark
Portfolio highlights
- Fibbl — Fibbl is the world's first cost-effective end-to-end solution for 3D and AR focused visual marketing. Integrate 3D & AR into e-commerce and marketing in minutes.Fibbl have industrialized the process of producing photorealistic 3D models for consumer products from global brands. Fibbl has the world's largest 3D model database forconsumer products.Learn more - https://www.fibbl.com/
- Agteria Biotech — Agteria Biotech is an innovative biotech startup dedicated to mitigating methane emissions in cattle through our groundbreaking compound. By promoting sustainable practices in livestock farming, we aim to engage investors and dairy companies interested in eco-friendly solutions. Partner with us to t
- Senseworks — Senseworks is an insight platform that enables colleagues to collaborate effectively with customers by providing a single source of truth for accounting data.
FundersClub focuses on Seed and early stage investments. Investments include Coinbase, Instacart, Flexport, Le Tote, Teespring, Memebox, GitLab.FundersClub is the world's first online venture capital platform. Backed by Y Combinator, First Round Capital, Spark Capital, Intel Capital, Draper, Andreessen Horowitz, Felicis Ventures, and more;FundersClub Inc. was founded in 2012 and is based in the United States.
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Series A, Funding Round
- United States, Canada, India
Portfolio highlights
- AthenaHQ — AthenaHQ is the one-stop-shop for marketers for everything AI Search.
- Sorcerer — Sorcerer builds weather balloons that fly for over six months, collecting 1000x more data per dollar and reaching previously inaccessible regions
- Momentic — Supercharge your QA process with Momentic's advanced AI tools for automated testing. Ship faster with reliable, AI-driven tests.
Innovation Fund Denmark invests in the development of new knowledge and technology creating growth and employment in Denmark. The Fund focuses on societal challenges, strengthens research, and increases innovation commitment within private companies.The Fund provides risk capital that enables cutting-edge initiatives to achieve resultssubstantially impacting the Danish society. Innovation Fund Denmark is also responsible for the future societal partnerships, where companies, universities, and public authorities will work together on challenges facing the society today.
Show more
Investment focus
- Software, Biotechnology, SaaS
- Grant, Pre-Seed, Seed
- Denmark, United States
Portfolio highlights
- SureShot — SureShot empowers you and your audience to become video co-creators. With our cutting-edge AI, capture, edit, and share electrifying videos that amplify the essence of every event.
- FEESH — FEESH is a groundbreaking biotech company developing sustainable protein alternatives targeted at the aquaculture industry.
- Tailwind Biotech — AI-powered synthetic DNA design services for improved strain development. We use Artificial Intelligence to help biotech companies achieve more effective and more efficient bioproduction processes. Our technology designs best-in-class synthetic DNA Promoters and Terminators, and performs gene codon optimizations that help to maximise biomanufacturing yields while reducing development costs.
The Yield Lab Europe is a €55m early stage Agrifood and Ag Tech fund which comprises an accelerator and a larger follow-on fund, investing in high tech companies with the potential to significant disrupt and improve our current systems of global food production, and to improve the environmental sustainability of the industry. The main fund invests€1m each into 10-12 companies over several follow on rounds, with the strongest accelerator companies expected to progress to the main fund. The Yield Lab Europe is also part of a global network of Agrifood Tech funds, with global headquarters in St Louis USA, and sister funds in LATAM and Singapore.
Show more
Investment focus
- AgTech, Agriculture, Biotechnology
- Seed, Series A, Funding Round
- Ireland, France, United Kingdom
Portfolio highlights
- Kapsera — Kapsera bridges the gap between sustainability and productivity in agriculture, using cutting-edge, biosourced and biodegradable formulation technologies.Kapsera offers natural and innovative formulations for microbials based biofertilizers and biopesticides.
- BiOceanOr — BiOceanOr harnessed the power of Marine Biology and AI to deliver bio-guided services that optimize fish welfare and fish growth, while supporting aquaculture sustainability standards
- Marama Labs — Marama Labs provides an integrated chemical analysis platform that empowers customers to optimize their production processes and match their products and brands to customer needs, with ease.
Dawn Biopharma is a global investment firm of KKR.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Seed, Series A, Series B
- Denmark, France, Belgium
Portfolio highlights
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- Antag Therapeutics — Antag Therapeutics operator of a biotechnology company intended to develop metabolic and anti-obesity therapeutic drugs.The company specializes in the development of peptide-based GIP receptor antagonist in order to monitor dietary-related metabolic diseases through the infusion, enabling the healthcare industry to decrease blood flow and lipiduptake in adipose tissue in an efficient manner.
- Bambusa Therapeutics — Bambusa Therapeutics operates as biotechnology company, that focuses on developing bispecific antibodies.
+ND Capital (NanoDimension) is a venture capital firm founded in 2002 that invests in disruptive technologies across the life, physical, and data sciences.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series C, Series A
- United States, Switzerland, Denmark
Portfolio highlights
- Vandria — At the vanguard of Mitochondrial research
- Constructive Bio — Constructive is a ground-breaking method for creating wholly artificial genomes and rewriting the genetic code of living things.
- PulseSight Therapeutics — PulseSight is an ophthalmology drug development company creating novel, non-viral gene therapies with minimally invasive delivery technology to address the unmet need for treatments against severe retinal diseases leading to blindness.
Northzone is a multi-stage venture capital fund that seeks to invest in the healthcare, semiconductors, software, hardware, artificial intelligence, blockchain, and gaming industries.
Show more
Investment focus
- Software, Information Technology, E-Commerce
- Series A, Series B, Seed
- United States, Sweden, United Kingdom
Portfolio highlights
- Nivoda — Nivoda provides jewellery businesses with a simple solution to strengthen profits, increase efficiency and accelerate growth with its B2B diamond marketplace. Designed to save you time and money whilst giving you access to the world’s diamond supply at the best prices with zero inventory risk, Nivoda is trusted by thousands of retailers all overthe globe.
- Tana — Tana is a software development company that reinvents how humans, teams, and computers work together. Tana was founded in 2020 and was headquartered in Oslo, Norway.
- Berry Street — Nutrition therapy by registered dietitians covered by insurance.
JJDC, Inc. is the strategic venture capital arm of Johnson & Johnson Innovation. Learn more about our equity investment strategy.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series C, Series B, Funding Round
- United States, United Kingdom, Canada
Portfolio highlights
- Binx Health — Binx Health is creating new categories of healthcare solutions that deliver on-demand testing to people where they need it most. With its proprietary, desktop, PCR-based point-of-care testing platforms and consumer mobile offerings, the company is redefining “convenient care” for the modern consumer
- Prana Thoracic — A minimally invasive, lung-sparing device that will provide physicians and patients with the certainty they need to move forward with treatment.
- Osteal Therapeutics — Osteal Therapeutics is a privately-held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences.
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- United States, United Kingdom, Switzerland
Portfolio highlights
- INBRACE — Swift Health Systems is a stealth stage medical device company developing INBRACE: a revolutionary, easy to use, wide indication, personalized orthodontic system hidden behind the teeth. Our patented self-guiding technology uses light and continuous forces to gently correct your smile with less pain and fewer doctor visits. INBRACE is FDAregistered and a catalyst for disruption in orthodontics. INBRACE increases the number of people who will seek orthodontic treatment by addressing the top concerns for patients while driving practice growth for clinicians. Our platform leverages digital treatment planning, computer modeling, and direct digital manufacturing to create a scalable, patient customized solution that delivers the standard of care across the entire range of orthodontic cases.
- Theraxyte — Theraxyte is an innovative nano-drug developer. It focuses on the R&D and application of new nano-drugs, especially innovative drugs.
- Amolyt Pharma — AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United States, United Kingdom, Switzerland
Portfolio highlights
- Biolinq — Introducing a revolutionary platform for metabolic health.
- ChEmpower — ChEmpower is an advanced materials company that develops chemically reactive, abrasive-free planarization pads to improve chip yields and sustainability in semiconductor manufacturing.
- Corvic AI — Corvic AI is pioneering a new era of Data-Centric AI Cognitive Infrastructure by transforming raw enterprise data into AI-ready intelligence.
Investors by industry
Consumer
Proptech
Impact
Climate
Gaming
Biotech
FinTech
Marketplace
Community
Health Care
Hardware
Energy
Artificial intelligence
Google
EdTech
Sustainability
Venture Capital
Real Estate
Music
Photography
Clean Energy
Education
B2B
Financial Services
Big Data
Payments
Finance
Art
Organic Food
Food and Beverage
Web3
Infrastructure
Retail
Beauty
Publishing
Wellness
Video Games
Hospitality
Platforms
Biotechnology
Cannabis
Mobile Advertising
Travel
Fitness
Recruiting
Franchise
Crowdfunding
Social
Medical Device
Automotive
Wine And Spirits
CleanTech
Mobile Apps
Transportation
Mobile
InsurTech
Enterprise
Local
Digital Media
Legal
LGBT
Android
eSports
Enterprise Software
Sports
Manufacturing
Email
Medical
Social Network
Social Media
Internet
Fashion
Oil and Gas
Construction
Life Science
Theatre
Film
Renewable Energy
Non Profit
SaaS
Celebrity
Sporting Goods
Restaurants
Social Impact
Software
Facebook
Cryptocurrency
Machine Learning
Agriculture (agtech)
Media (entertainment)
Blockchain
Investors by country
Canada
Germany
United Kingdom
Ireland
South Korea
India
Australia
New Zealand
United States
Middle East
Brazil
LATAM
Qatar
Indonesia
Asia
Europe
Spain
South Africa
Singapore
Armenia
Saudi Arabia
Sri Lanka
China
Africa
Oceania
Japan
Vietnam
Belarus
Chile
Belgium
Hong Kong
Finland
Ghana
Georgia
Ethiopia
Gibraltar
Faroe Islands
Denmark
Egypt
Estonia
Costa Rica
Hungary
Greece
Barbados
Croatia
Belize
Bahrain
Czech Republic
Algeria
Ecuador
Bulgaria
Bermuda
France
Kuwait
Malta
Morocco
Nicaragua
Mali
Lithuania
Peru
Lebanon
Jersey
Norway
Myanmar
Mauritius
Liberia
Mexico
Malaysia
Liechtenstein
Philippines
Italy
Israel
Panama
Poland
Senegal
Sierra Leone
Tunisia
Togo
Serbia
Turkey
San Marino
Thailand
Uzbekistan
Taiwan
Sweden
Tanzania
Slovenia
El Salvador
Portugal
Tajikistan
Ukraine
Puerto Rico
Uganda
Venezuela
Uruguay
Zambia
Zimbabwe
Rwanda
Russian Federation
Dominican Republic
Nigeria
Iraq
Azerbaijan
Bahamas
Iceland
Namibia
United Arab Emirates
Jamaica
Honduras
Bolivia
Isle of Man
Luxembourg
Albania
Pakistan
Grenada
Jordan
Bangladesh
Argentina
Romania
Kazakhstan
Kenya
Cayman Islands
Cambodia
Latvia
Cyprus
Oman
Cameroon
Austria
Switzerland
Colombia
Guatemala
Seychelles
Marshall Islands
Investors in Denmark by industry
Restaurants
Transportation
Social
Big Data
Education
Cryptocurrency
Finance
Food and Beverage
Payments
Mobile Apps
Medical
Medical Device
Financial Services
Fitness
Sports
Social Media
Manufacturing
Internet
Art
Music
Blockchain
Mobile
Legal
Software
eSports
Enterprise Software
Hospitality
Travel
Automotive
Platforms
Recruiting
Biotechnology
FinTech
Enterprise
Health Care
Consumer
EdTech
Biotech
Climate
Sustainability
Energy
Impact
Proptech
Community
SaaS
Hardware
Retail
Life Science
Beauty
B2B
Wellness
Sporting Goods
Renewable Energy
Gaming
Real Estate
Construction
CleanTech
Non Profit
Web3
Artificial intelligence
Marketplace
Social Network
Agriculture (agtech)
Media (entertainment)
Photography
Fashion
Publishing
Social Impact
Machine Learning
Video Games
Clean Energy